Facebook Twitter LinkedIn Google Plus RSS

Pacira Pharmaceuticals announces proposed public offering of stock

By ,

Parsippany-based Pacira Pharmaceuticals Inc. announced Tuesday that it is offering $100 million of its common stock in a proposed public offering.

According to the release, Pacira plans to grant underwriters 30 days to purchase up to $15 million of additional shares.

Jeffries LLC, Barclays Capital Inc. and BofA Merrill Lynch are acting as the joint bookrunning managers and underwriters for the offering.

ALSO ON NJBIZ:

Green developer Jonathan F. P. Rose preaches sustainability with South Orange site

NJBIZ names the 2014 General Counsel of the Year finalists

Small business owners: Stronger NJ grant process not working

More From This Industry

Emily Bader

Emily Bader

Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com or @emilybader on Twitter.

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!